Abstract

Insights

The novel bromodomain-containing protein 4 (BRD4) inhibitor AZD5153 effectively reduced prostate cancer cell proliferation and survival. Combination therapy with an AKT inhibitor enhanced AZD5153

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Bromodomain-containing protein 4 (BRD4) overexpression drives prostate cancer progression by upregulating oncogenes.
  • AZD5153 is a novel inhibitor targeting BRD4.

Purpose of the Study:

  • To evaluate the therapeutic potential of AZD5153 in prostate cancer.
  • To investigate the mechanisms underlying AZD5153's efficacy and resistance.

Main Methods:

  • In vitro studies utilized prostate cancer cell lines treated with AZD5153, assessing survival, proliferation, apoptosis, cell cycle, and signaling pathways.
  • In vivo efficacy was tested using a PC-3 xenograft model in nude mice.
  • AKT's role as a resistance factor was investigated through inhibition and depletion studies.

Main Results:

  • AZD5153 inhibited prostate cancer cell proliferation and survival, inducing apoptosis and cell cycle arrest.
  • The drug downregulated key BRD4 targets, including cyclin D1, Myc, Bcl-2, FOSL1, and CDK4.
  • AKT was identified as a resistance factor; its inhibition sensitized cells to AZD5153 and enhanced anti-tumor activity in vivo when combined with MK-2206.

Conclusions:

  • AZD5153 demonstrates significant anti-prostate cancer activity by targeting BRD4.
  • Combining AZD5153 with AKT inhibitors like MK-2206 may represent a potent therapeutic strategy for prostate cancer.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
229
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.4K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.1K
Primary and Secondary Growth in Roots and Shoots03:02

Primary and Secondary Growth in Roots and Shoots

Vascular plants, which account for over 90% of the Earth’s vegetation, all undergo primary growth—which lengthens roots and shoots. Many land plants, notably woody plants, also undergo secondary growth—which thickens roots and shoots.
60.5K
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.6K